Molecules · 2021 · 36 citations · 35 references
PharmacyMedicinal ChemistryOncologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryHeterocyclic ChemistryStructure-activity Relationship AnalysisAnticancer ActivityAnticancer Compound ScreeningAntiproliferative AgentsAntiproliferative Drug ActionMolecular Docking AnalysisPyrrole ChemistryQuinoline ChemistryQuinoline Synthesis
Several new cyano-substituted derivatives with pyrrolo[1,2-a]quinoline and pyrrolo[2,1-a]isoquinoline scaffolds were synthesized by the [3 + 2] cycloaddition of (iso)quinolinium ylides to fumaronitrile. The cycloimmonium ylides reacted in situ as 1,3-dipoles with fumaronitrile to selectively form distinct final compounds, depending on the structure of the (iso)quinolinium salt. Eleven compounds were evaluated for their anticancer activity against a panel of 60 human cancer cell lines. The most potent compound 9a showed a broad spectrum of antiproliferative activity against cancer cell lines representing leukemia, melanoma and cancer of lung, colon, central nervous system, ovary, kidney, breast and prostate cancer. In vitro assays and molecular docking revealed tubulin interaction properties of compound 9a.
35
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
Marcus D. Hanwell, Donald Curtis, David Lonie et al. · Journal of Cheminformatics · 2012 · 10.4K citations · Full text
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Promotion of microtubule assembly in vitro by taxol
Peter B. Schiff, Jane Fant, Susan Band Horwitz · Nature · 1979 · 3.6K citations
Comprehensive review on current developments of quinoline-based anticancer agents
Shweta Jain, Vikash Chandra, Pankaj Jain et al. · Arabian Journal of Chemistry · 2016 · 385 citations · Full text